Results 71 to 80 of about 84,518 (238)

Lichens Mentioned by Pedanios Dioscorides [PDF]

open access: yes, 2012
Lichens are included in the classification system of fungi and have been used in medicine, pharmacy and industry from antiquity to present day in the treatment of various diseases.
Yavuz, Mustafa
core  

Recent advances of NFATc1 in rheumatoid arthritis-related bone destruction: mechanisms and potential therapeutic targets

open access: yesMolecular Medicine
Rheumatoid arthritis (RA) is a chronic autoimmune inflammatory disease characterized by inflammation of the synovial tissue and joint bone destruction, often leading to significant disability.
Hao Zheng   +12 more
doaj   +1 more source

Danshen-Shanzha formula for the treatment of atherosclerosis: ethnopharmacological relevance, preparation methods, chemical constituents, pharmacokinetic properties, and pharmacological effects

open access: yesFrontiers in Pharmacology
Danshen-Shanzha Formula (DSF) is a well-known herbal combination comprising Radix Salvia Miltiorrhiza (known as Danshen in Chinese) and Fructus Crataegi (known as Shanzha in Chinese), It has been documented to exhibit considerable benefits for promoting ...
Qiong Xu   +8 more
doaj   +1 more source

Resveratrol ameliorates atherosclerosis induced by high-fat diet and LPS in ApoE−/− mice and inhibits the activation of CD4+ T cells

open access: yesNutrition & Metabolism, 2020
Background Atherosclerosis (AS), which characterized with the accumulation of lipids on the vessel wall, is the pathological basis of many cardiovascular diseases (CVD) and seriously threatens human health.
Liyu Zhou   +5 more
doaj   +1 more source

Isavuconazole and Calcium Channel Blocker for Invasive Fungal Disease Accompanied With Hypertension: Evidence From the FAERS and PBPK/PD Model

open access: yesCPT: Pharmacometrics &Systems Pharmacology, EarlyView.
Safety assessment of ISA in combination with CCBs. Disproportionality analysis through the FAERS database showed that ISA was not associated with drug‐induced hypertension and DDI‐caused hypotension, whereas CCBs (nifedipine and amlodipine) were the most common co‐medications for hypotension occurring in combination with TADs.
Jianxing Zhou   +9 more
wiley   +1 more source

Old School Catalog 1907-08, Annual Catalog [PDF]

open access: yes, 1907
https://scholar.valpo.edu/oldschoolcatalogs/1027/thumbnail ...
Valparaiso University
core   +1 more source

Effective extraction of Xuetongsu and its role in preventing RA synovial hyperplasia by targeting synovial cell migration and apoptosis

open access: yesScientific Reports
Kadsura heteroclita (Roxb) Craib also named Xuetong in Tujia ethnomedicine in China, has been traditionally employed in rheumatoid arthritis (RA) treatment.
Yasi Deng   +13 more
doaj   +1 more source

An Up‐to‐Date Review of Traditional Chinese Medicine in the Treatment of Atherosclerosis: Components, Mechanisms, and Therapeutic Potentials

open access: yesPhytotherapy Research, EarlyView.
Traditional Chinese medicine in atherosclerosis: multi‐target modulation of pathogenesis. ABSTRACT Atherosclerosis is a chronic inflammatory disease and a major global health concern. In recent years, traditional Chinese medicines (TCMs) have demonstrated multi‐target therapeutic potential against atherosclerosis by modulating inflammatory responses ...
Dilaram Nijat   +5 more
wiley   +1 more source

Understanding of endo/lysosomal escape of nanomaterials in biomedical application

open access: yesSmart Molecules, EarlyView.
This review summarized mainstream mechanisms of endo/lysosomal escape and design strategies of endo/lysosomal escapable nanoparticles in view of surface charge, polarity & hydrophobicity, particle morphology, and lysosomal escape agents. The utilization of endo/lysosomal escapable nanoparticles for vaccine delivery and genetic engineering are ...
Xin Wang   +3 more
wiley   +1 more source

Old School Catalog 1906-07, Annual Catalog [PDF]

open access: yes, 1906
https://scholar.valpo.edu/oldschoolcatalogs/1031/thumbnail ...
Valparaiso University
core   +1 more source

Home - About - Disclaimer - Privacy